TY - JOUR
T1 - Cell graph neural networks enable the precise prediction of patient survival in gastric cancer
AU - Wang, Yanan
AU - Wang, Yu Guang
AU - Hu, Changyuan
AU - Li, Ming
AU - Fan, Yanan
AU - Otter, Nina
AU - Sam, Ikuan
AU - Gou, Hongquan
AU - Hu, Yiqun
AU - Kwok, Terry
AU - Zalcberg, John
AU - Boussioutas, Alex
AU - Daly, Roger J.
AU - Montúfar, Guido
AU - Liò, Pietro
AU - Xu, Dakang
AU - Webb, Geoffrey I.
AU - Song, Jiangning
N1 - Funding Information:
The authors would like to thank the Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine for providing support for this project. We would also like to thank all the collaborators and colleagues for the enlightening discussions and feedback. This work was supported by the Major Inter-Disciplinary Research (IDR) Grant awarded by Monash University and project grants from the National Natural Science Foundation of China (NSFC) (81871274, 82071811, and 31670905).
Funding Information:
The authors would like to thank the Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine for providing support for this project. We would also like to thank all the collaborators and colleagues for the enlightening discussions and feedback. This work was supported by the Major Inter-Disciplinary Research (IDR) Grant awarded by Monash University and project grants from the National Natural Science Foundation of China (NSFC) (81871274, 82071811, and 31670905).
Publisher Copyright:
© 2022, The Author(s).
PY - 2022
Y1 - 2022
N2 - Gastric cancer is one of the deadliest cancers worldwide. An accurate prognosis is essential for effective clinical assessment and treatment. Spatial patterns in the tumor microenvironment (TME) are conceptually indicative of the staging and progression of gastric cancer patients. Using spatial patterns of the TME by integrating and transforming the multiplexed immunohistochemistry (mIHC) images as Cell-Graphs, we propose a graph neural network-based approach, termed Cell−GraphSignatureorCGSignature, powered by artificial intelligence, for the digital staging of TME and precise prediction of patient survival in gastric cancer. In this study, patient survival prediction is formulated as either a binary (short-term and long-term) or ternary (short-term, medium-term, and long-term) classification task. Extensive benchmarking experiments demonstrate that the CGSignature achieves outstanding model performance, with Area Under the Receiver Operating Characteristic curve of 0.960 ± 0.01, and 0.771 ± 0.024 to 0.904 ± 0.012 for the binary- and ternary-classification, respectively. Moreover, Kaplan–Meier survival analysis indicates that the “digital grade” cancer staging produced by CGSignature provides a remarkable capability in discriminating both binary and ternary classes with statistical significance (P value < 0.0001), significantly outperforming the AJCC 8th edition Tumor Node Metastasis staging system. Using Cell-Graphs extracted from mIHC images, CGSignature improves the assessment of the link between the TME spatial patterns and patient prognosis. Our study suggests the feasibility and benefits of such an artificial intelligence-powered digital staging system in diagnostic pathology and precision oncology.
AB - Gastric cancer is one of the deadliest cancers worldwide. An accurate prognosis is essential for effective clinical assessment and treatment. Spatial patterns in the tumor microenvironment (TME) are conceptually indicative of the staging and progression of gastric cancer patients. Using spatial patterns of the TME by integrating and transforming the multiplexed immunohistochemistry (mIHC) images as Cell-Graphs, we propose a graph neural network-based approach, termed Cell−GraphSignatureorCGSignature, powered by artificial intelligence, for the digital staging of TME and precise prediction of patient survival in gastric cancer. In this study, patient survival prediction is formulated as either a binary (short-term and long-term) or ternary (short-term, medium-term, and long-term) classification task. Extensive benchmarking experiments demonstrate that the CGSignature achieves outstanding model performance, with Area Under the Receiver Operating Characteristic curve of 0.960 ± 0.01, and 0.771 ± 0.024 to 0.904 ± 0.012 for the binary- and ternary-classification, respectively. Moreover, Kaplan–Meier survival analysis indicates that the “digital grade” cancer staging produced by CGSignature provides a remarkable capability in discriminating both binary and ternary classes with statistical significance (P value < 0.0001), significantly outperforming the AJCC 8th edition Tumor Node Metastasis staging system. Using Cell-Graphs extracted from mIHC images, CGSignature improves the assessment of the link between the TME spatial patterns and patient prognosis. Our study suggests the feasibility and benefits of such an artificial intelligence-powered digital staging system in diagnostic pathology and precision oncology.
UR - http://www.scopus.com/inward/record.url?scp=85132576741&partnerID=8YFLogxK
U2 - 10.1038/s41698-022-00285-5
DO - 10.1038/s41698-022-00285-5
M3 - Article
C2 - 35739342
AN - SCOPUS:85132576741
SN - 2397-768X
VL - 6
JO - npj Precision Oncology
JF - npj Precision Oncology
IS - 1
M1 - 45
ER -